Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
ethyl 4-bromo-5-methyl-1H-pyrazole-3-carboxylate → 4-bromo-N,N-dibutyl-5-methyl-1H-pyrazole-3-carboxamide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | ethyl 4-bromo-5-methyl-1H-pyrazole-3-carboxylate | HCID 616098 | — |
| 반응물 | N,N-dibutyl-4-chloro-5-methyl-1H-pyrazole-3-carboxamide | HCID 71062189 | — |
| 생성물 | 4-bromo-N,N-dibutyl-5-methyl-1H-pyrazole-3-carboxamide | HCID 47370163 | 75% |
반응 단계
Following a procedure analogous to that for the synthesis of Intermediate 1B, ethyl 4-bromo-5-methyl-1H-pyrazole-3-carboxylate (Tabrizi, M. A. et al., Bioorg. Med. Chem., 16:2419-2430 (2008)) (5.68 g, 24.4 mmol) was converted to the title compound (5.79 g, 75%). 1H NMR (CDCl3) δ 3.51 (t, J=7.4 Hz, 2H), 3.38-3.26 (m, 2H), 2.34 (s, 3H), 1.73-1.34 (m, 6H), 1.22-1.13 (m, 2H), 1.03-0.75 (m, 6H); MS(ESI+) m/z 316.2 (M+H)+.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US09346795B2 |
| 출처 데이터셋 | uspto-grants-2016_05 |
| ORD ID | ord-f623520f9c7149d39e8e4bea76b97e97 |
| 출처 메모 | uspto-grants-2016_05 |